- Could You Spot the Silent Symptoms of Stress?
- Gas Stoves Could Leave Your Lungs Vulnerable to Nitrogen Dioxide
- Key Therapy Equally Effective for Women, Men With Narrowed Leg Arteries
- Doctors Describe Texas Dairy Farm Worker’s Case of Bird Flu
- Does Preschool Boost Kids’ Long-Term Academic Success? Study Finds Mixed Results
- AI Might Spot Rare Diseases in Patients Years Earlier
- An Orangutan Healed Himself With Medicinal Plant
- Quit-Smoking Meds Not Working for You? Try Upping the Dose
- Fewer Americans Are Suffering Most Dangerous Form of Heart Attack
- Even Skipping Meat for One Meal Helps Liver Disease Patients
Narcan Nasal Spray Approved to Counter Narcotic Painkiller Overdose
Narcan (naloxone hydrochloride) nasal spray has been approved by the U.S. Food and Drug Administration to stop or reverse an overdose of opioids, a class of narcotic drugs that includes the prescription medication oxycodone (Oxycontin) and the illicit drug heroin.
Symptoms of overdose with these drugs could include shallow breathing and difficulty waking a person. Drug overdoses have surpassed traffic accidents as the leading cause of injury death in the United States, the FDA said in a news release.
Narcan, if given soon enough, can reverse the effects of an overdose in as little as two minutes, the agency said. The drug was approved previously as an injection. However, many first responders believe a nasal spray is easier to deliver and avoids the possibility of needle contamination, the FDA said. However, the drug is not meant to substitute for immediate medical care.
In clinical testing, the nasal spray given in one nostril had about the same effectiveness as the drug’s injected form, the FDA said.
If the drug is given to people who are dependent on narcotic painkillers or heroin, they may develop symptoms of severe opioid withdrawal, including body aches, diarrhea, rapid heartbeat, fever, runny nose and sneezing, the agency said.
Narcan nasal spray is distributed by Adapt Pharma, based in Radnor, Penn.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.